Previous close | 8.60 |
Open | N/A |
Bid | 13.10 |
Ask | 13.60 |
Strike | 195.00 |
Expiry date | 2024-08-16 |
Day's range | 8.60 - 8.60 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Lucid Diagnostic's (LUCD) ESOGUARD BE-1 study data shows high sensitivity and negative predictive value for the EsoGuard test, enhancing early detection of esophageal precancer in a screening population.
DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
KORU Medical (KRMD) announces the receipt of regulatory clearance for its FreedomEdge System in Japan.